HealthTree Logo
search more_vert
close
person Sign In / Create Account
All Facilities
/
NC
/
Duke University Medical Center
/
Harry Erba

Clinical Expertise

Dr. Erba's research focus is on clinical development of novel therapies for acute myeloid leukemia, myelodysplastic syndromes, myeloproliferative neoplasms (such as chronic myeloid leukemia, polycythemia vera, essential thrombocythemia and myelofibrosis), and acute lymphoblastic leukemia. Specifically, he has been the Principal Investigator for small molecular inhibitors, antibody-drug conjugates and cytotoxic chemotherapy. Dr. Erba has been an active member of teams of doctors that have brought new treatments to people with AML, such as oral drugs that inactivate FLT3 and IDH.

Location

Duke University Medical Center: Ambulatory Surgery Center, 2400 Pratt St, Durham, NC 27705, USA

Get the latest thought leadership on Chronic Myeloid Leukemia delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Chronic Myeloid Leukemia Newsletter" for Chronic Myeloid Leukemia news, life with Chronic Myeloid Leukemia stories, Chronic Myeloid Leukemia clinical trials, Chronic Myeloid Leukemia 101 articles and events with Chronic Myeloid Leukemia experts.

Charity Navigator https://www.guidestar.org/profile/45-5354811

HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.

Copyright © 2023 HealthTree Foundation. All rights reserved.

Tax ID 45-5354811